Activation of microRNA-494-targeting Bmi1 and ADAM10 by silibinin ablates cancer stemness and predicts favourable prognostic value in head and neck squamous cell carcinomas-Reference-Cited by-同舟云学术

Activation of microRNA-494-targeting Bmi1 and ADAM10 by silibinin ablates cancer stemness and predicts favourable prognostic value in head and neck squamous cell carcinomas

Published:2015-06-08 Issue:27 Volume:6 Page:24002-24016
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Chang Yu-Chao¹²³,Jan Chia-Ing⁴⁵,Peng Chih-Yu¹²³,Lai Yu-Chi⁶,Hu Fang-Wei¹²⁶³,Yu Cheng-Chia¹²⁶³

Affiliation:

1. School of Dentistry, Chung Shan Medical University, Taichung, Taiwan

2. Department of Dentistry, Chung Shan Medical University Hospital, Taichung, Taiwan

3. Oral Medicine Research Center, Chung Shan Medical University, Taichung, Taiwan

4. Department of Pathology, China Medical University Hospital, Taichung, Taiwan

5. Department of Pathology, China Medical University Beigang Hospital, Yunlin, Taiwan

6. Institute of Oral Sciences, Chung Shan Medical University, Taichung, Taiwan

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comprehensive review on the use of traditional Chinese medicine for cancer treatment;Pharmacological Research - Modern Chinese Medicine;2024-06

2. Unravelling the role of Silibinin in targeting CD44+ cancer stem cells: Therapeutic implications, effective strategies and approaches;Phytotherapy Research;2024-02-14

3. Treatment failure shortcomings, possible causes and upcoming phyto-optimism in oral cancer;The Applied Biology & Chemistry Journal;2023-03-31

4. Inhibition of Cancer Stem Cells Growth with Silibinin Encapsulated in Nanoparticles with Deregulation of miR-34a, miR-221, and miR-222;Iranian Red Crescent Medical Journal;2023-03-25

5. Mechanisms involved in cancer stem cell resistance in head and neck squamous cell carcinoma;Cancer Drug Resistance;2023